1. Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent 
Michael Argenziano, MD, Jonathan M. Chen, MD, Asim F. Choudhri, BS, Suzanne Cullinane, BA, Evan Garfein, BA, Alan D. Weinberg, MS, Craig R. Smith, MD, Eric A. Rose, MD, Donald W. Landry, MD, PhD, Mehmet C. Oz, MD 
The Journal of Thoracic and Cardiovascular Surgery 
Volume 116, Issue 6, Pages (December 1998)
DOI: /S (98)
Copyright © 1998 Mosby, Inc. Terms and Conditions

2. Fig. 1
Distribution of AVP levels in cardiogenic and vasodilatory shock.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) )
Copyright © 1998 Mosby, Inc. Terms and Conditions

3. Fig. 2
Relationship between degree of baseline hypotension and increase in mean arterial pressure (MAP) after AVP infusion in 40 LVAD and OHT recipients.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) )
Copyright © 1998 Mosby, Inc. Terms and Conditions

4. Fig. 3
Relationship between degree of baseline hypotension and increase in systemic vascular resistance (SVR) after AVP infusion in 40 LVAD and OHT recipients. MAP, Mean arterial pressure.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) )
Copyright © 1998 Mosby, Inc. Terms and Conditions

5. Fig. 4
Relationship between degree of baseline hypotension and decrease in norepinephrine (NE) requirements after AVP infusion in 40 LVAD and OHT recipients. MAP, Mean arterial pressure.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) )
Copyright © 1998 Mosby, Inc. Terms and Conditions